Literature DB >> 8542896

Serial indium-111-labelled IgG biodistribution in rat Pneumocystis carinii pneumonia: a tool to monitor the course and severity of the infection.

R M Perenboom1, W J Oyen, A C van Schijndel, P Beckers, F H Corstens, J W van der Meer.   

Abstract

To study the effect of new therapeutic strategies, we developed an animal model to monitor the course and severity of experimental Pneumocystis carinii pneumonia (PCP) in rats. P. carinii density scores in Giemsa-stained impression smears were used to follow P. carinii load. Indium-111 labelled IgG scintigraphy and biodistribution, histology of paraffin-embedded tissue sections, lung/body weight (L/B wt) ratio and cell count and differentiation of broncho-alveolar lavage (BAL) fluid were used as parameters of host inflammatory response. Statistically significant differences in L/B wt ratio, number of neutrophils in BAL fluid, P. carinii density score, histological extent of inflammation and 111In-IgG accumulation in the lung were seen between the rats sacrificed at various time points. 111In-IgG accumulation in the lung correlated well with L/B wt ratio and P. carinii density score and correlated moderately with number of neutrophils in BAL fluid and with the histological extent of inflammation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8542896     DOI: 10.1007/bf00800594

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  13 in total

1.  Biodistribution and kinetics of radiolabeled proteins in rats with focal infection.

Authors:  W J Oyen; R A Claessens; J W van der Meer; F H Corstens
Journal:  J Nucl Med       Date:  1992-03       Impact factor: 10.057

2.  Imaging of Pneumocystis carinii pneumonia with 111In-labelled non-specific polyclonal IgG: an experimental study in rats.

Authors:  J A Fishman; H W Strauss; A J Fischman; M Nedelman; R Callahan; B A Khaw; R H Rubin
Journal:  Nucl Med Commun       Date:  1991-03       Impact factor: 1.690

Review 3.  Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients.

Authors:  A E Glatt; K Chirgwin
Journal:  Arch Intern Med       Date:  1990-02

4.  Growth characteristics and pathogenesis of experimental Pneumocystis carinii pneumonia.

Authors:  P D Walzer; R D Powell; K Yoneda; M E Rutledge; J E Milder
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

Review 5.  Pathogenesis of hypersensitivity reactions to drugs in patients with HIV infection: allergic or toxic?

Authors:  P P Koopmans; A J van der Ven; T B Vree; J W van der Meer
Journal:  AIDS       Date:  1995-03       Impact factor: 4.177

6.  Interaction of Pneumocystis carinii with host lungs: an ultrastructural study.

Authors:  K Yoneda; P D Walzer
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

7.  Indium-111 labelled pooled human immunoglobulin imaging to monitor the efficacy of specific therapy for Pneumocystis carinii pneumonia.

Authors:  J R Buscombe; I Khalkhali; G R Mason; D Rauh; J Meatherall; W J Oyen; F H Corstens
Journal:  Eur J Nucl Med       Date:  1994-10

8.  Comparison of histologic and quantitative techniques in evaluation of therapy for experimental Pneumocystis carinii pneumonia.

Authors:  C K Kim; J M Foy; M T Cushion; D Stanforth; M J Linke; H L Hendrix; P D Walzer
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

9.  The preparation of DTPA-coupled antibodies radiolabeled with metallic radionuclides: an improved method.

Authors:  D J Hnatowich; R L Childs; D Lanteigne; A Najafi
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

10.  Dissociation of indium from indium-111-labelled diethylene triamine penta-acetic acid conjugated non-specific polyclonal human immunoglobulin G in inflammatory foci.

Authors:  R A Claessens; E B Koenders; O C Boerman; W J Oyen; G F Borm; J W van der Meer; F H Corstens
Journal:  Eur J Nucl Med       Date:  1995-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.